Russell E. Lewis

Active 1996–2025

Also published as
Russell E Lewis
137
Papers
22,426
Citations
89
h-index
134
i10-index

Citations

Citations per year for Russell E. Lewis1989: 1 citations1994: 2 citations1997: 1 citations1998: 1 citations1999: 3 citations2000: 12 citations2001: 9 citations2002: 13 citations2003: 46 citations2004: 48 citations2005: 93 citations2006: 101 citations2007: 160 citations2008: 126 citations2009: 168 citations2010: 166 citations2011: 188 citations2012: 151 citations2013: 132 citations2014: 182 citations2015: 145 citations2016: 162 citations2017: 166 citations2018: 158 citations2019: 591 citations2020: 691 citations2021: 908 citations2022: 660 citations2023: 455 citations2024: 668 citations2025: 342 citations2026: 5 citations1990–1993: no citations, so these years are not shown1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,664 citing papers, 20.2% of this breakdownItaly: 512 citing papers, 6.2% of this breakdownChina: 435 citing papers, 5.3% of this breakdownGermany: 423 citing papers, 5.1% of this breakdownUnited Kingdom: 420 citing papers, 5.1% of this breakdownFrance: 416 citing papers, 5% of this breakdownSpain: 369 citing papers, 4.5% of this breakdownIndia: 312 citing papers, 3.8% of this breakdownNetherlands: 272 citing papers, 3.3% of this breakdownAustralia: 254 citing papers, 3.1% of this breakdownAustria: 236 citing papers, 2.9% of this breakdownBrazil: 230 citing papers, 2.8% of this breakdown
0%20.2%Other 32.7%

Fields

  • Medicine72.5%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Immunology and Microbiology4.7%
  • Agricultural and Biological Sciences2.1%
  • Chemistry0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other2.7%

Topics

  • Antifungal resistance and susceptibility20.3%
  • Fungal Infections and Studies13.4%
  • Antibiotic Resistance in Bacteria5.2%
  • Antibiotics Pharmacokinetics and Efficacy3.1%
  • Pneumocystis jirovecii pneumonia detection and treatment2.6%
  • Antibiotic Use and Resistance2.4%
  • Other53%

Coauthors

All papers

Open in search
  1. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claus Peter Heußel, C Kibbler, Н Н Климко, Bart Jan Kullberg, Christoph Lange, Thomas Lehrnbecher, Jürgen Löffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Jacques F. Meis, Livio Pagano, Patricia Ribaud, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Maurizio Sanguinetti, Donald C. Sheppard, János Sinkó, Anna Skiada, Maria J. G. T. Vehreschild, Claudio Viscoli, Oliver A. Cornely - Clinical Microbiology and Infection 2018 cited by 1,518

  2. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jesús Guinea, Claus Peter Heußel, Ashraf S. Ibrahim, Souha S. Kanj, Н Н Климко, Michaela Lackner, Frédéric Lamoth, Fanny Lanternier, Cornelia Lass-Floerl, Dong‐Gun Lee, Thomas Lehrnbecher, B. Lmimouni, Mihai Mareș, Georg Maschmeyer, Jacques F. Meis, Joseph Meletiadis, C. Orla Morrissey, Márcio Nucci, Rita Oladele, Livio Pagano, Alessandro C. Pasqualotto, Atul Patel, Zdeněk Ráčil, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Seyedmojtaba Seyedmousavi, Neeraj Sidharthan, Nina Singh, János Sinkó, Anna Skiada, Monica A. Slavin, Rajeev Soman, Brad Spellberg, William J. Steinbach, Ban Hock Tan, Andrew J. Ullmann, Jörg Janne Vehreschild, Maria J. G. T. Vehreschild, Thomas J. Walsh, P. Lewis White, Nathan P. Wiederhold, Theoklis E. Zaoutis, Arunaloke Chakrabarti - The Lancet Infectious Diseases 2019 cited by 1,756

  3. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefano Ianniruberto, Luciano Attard, Marina Tadolini Francesca Volpato, Giulio Virgili, Nicolò Rossi, Elena Rosselli Del Turco, Viola Guardigni, Giovanni Fasulo, Nicola Dentale, Ciro Fulgaro, Giorgio Legnani, Emanuele Campaci, Cristina Basso, Alberto Zuppiroli, Amalia Sanna Passino, Giulia Tesini, Lucia Angelelli, Adriana Badeanu, Agostino Rossi, Giulia Santangelo, Flovia Dauti, Vidak Koprivika, Nicholas Roncagli, Ioannis Tzimas, Guido Maria Liuzzi, Irid Baxhaku, Letizia Pasinelli, Mattia Neri, Tommaso Zanaboni, Francesco Dell’Omo, Alice Gori, Idina Zavatta, Stefano Antonini, Chiara Pironi, Elena Piccini, Luca Esposito, Alessandro Zuccotti, Giacomo Urbinati, Agnese Pratelli, A Sarti, Michela Semprini, Enrico Evangelisti, Mara D’Onofrio, Giuseppe Sasdelli - Clinical Infectious Diseases 2020 cited by 487

  4. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2020 cited by 454

  5. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacques F. Meis, M. Hong Nguyen, Zoi Dorothea Pana, Peter‐Michael Rath, Ilana Reinhold, Danila Seidel, Takahiro Takazono, Donald C. Vinh, Sean X. Zhang, Javier Afeltra, Abdullah M. S. Al‐Hatmi, Amir Arastehfar, Sevtap Arıkan-Akdağlı, Felix Bongomin, Fabianne Carlesse, Methee Chayakulkeeree, Louis Yi Ann Chai, Leili Chamani‐Tabriz, Tom Chiller, Anuradha Chowdhary, Cornelius J. Clancy, Arnaldo Lopes Colombo, Andrea Cortegiani, Dora Corzo-León, Ľuboš Drgoňa, Anna Dudakova, Joveria Farooqi, Sara Gago, Macit İlkit, Jeffrey D. Jenks, Н Н Климко, Robert Krause, Anil Kumar, Katrien Lagrou, Michail S. Lionakis, B. Lmimouni, Michael K. Mansour, Joseph Meletiadis, Sibylle C. Mellinghoff, Mervyn Mer, Małgorzata Mikulska, Philippe Montravers, Chin Fen Neoh, Volkan Özenci, Livio Pagano, Peter G. Pappas, Thomas F. Patterson, Pedro Puerta‐Alcalde, Laman Rahimli, Sebastian Rahn, Emmanuel Roilides, Coleman Rotstein, Tamara Ruegamer, Raquel Sabino, Jon Salmanton‐García, Ilan S. Schwartz, Esther Segal, Neeraj Sidharthan, Tanu Singhal, János Sinkó, Rajeev Soman, Andrej Spec, Joerg Steinmann, Jannik Stemler, Saad J. Taj‐Aldeen, Alida Fe Talento, George R Thompson, Christina Toebben, Hiram Villanueva‐Lozano, Retno Wahyuningsih and 5 more - The Lancet Infectious Diseases 2025 cited by 296

  6. Delaying Amphotericin B–Based Frontline Therapy Significantly Increases Mortality among Patients with Hematologic Malignancy Who Have Zygomycosis

    Authors: , , - Clinical Infectious Diseases 2008 cited by 812

  7. Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists

    Authors: , , , , , , , , , - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2023 cited by 92

  8. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study

    Authors: , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2014 cited by 257

  9. Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B

    Authors: , , , , , - Clinical Infectious Diseases 2019 cited by 127

  10. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Intensive Care Medicine 2021 cited by 162

  11. Current Concepts in Antifungal Pharmacology

    Authors: - Mayo Clinic Proceedings 2011 cited by 370

  12. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher P. Fox, Corrado Girmenia, Andreas H. Groll, Dag Heldal, Jannick Helweg Larsen, Raoul Herbrecht, Hans H. Hirsch, Elisabeth Johnson, G. A. Klyasova, Minna Koskuenvo, Katrien Lagrou, Russell E. Lewis, Per Ljungman, Johan Maertens, Georg Maschmeyer, Małgorzata Mikulska, Márcio Nucci, Christophe Padoin, Livio Pagano, Antonio Pagliuca, Zdeněk Ráčil, Patricia Ribaud, Christine Rinaldo, Valérie Rizzi Puechal, Emmanuel Roilides, Christine Robin, Montserrat Rovira, Markus Rupp, Sonia P. Sanchez, Peter Schellongowski, Petr Sedlacek, János Sinkó, Monica A. Slavin, Isabella Sousa Ferreira, Jan Styczyński, Frédéric Tissot, Claudio Viscoli, Katherine N. Ward, Anne‐Therese Witschi - Journal of Infection 2017 cited by 196

  13. Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance

    Authors: , , , , , , - The Journal of Infectious Diseases 2011 cited by 165

  14. In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment

    Authors: , , , , , , , , , , , - Journal of Antimicrobial Chemotherapy 2018 cited by 166

  15. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis

    Authors: , , , , , - Clinical Microbiology and Infection 2016 cited by 167

  16. Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , - The Journal of Infectious Diseases 2020 cited by 165

  17. Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection?

    Authors: , , , - The Lancet Haematology 2021 cited by 69

  18. Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods

    Authors: , , , , - Antimicrobial Agents and Chemotherapy 1998 cited by 338

  19. Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions

    Authors: , , - Clinical Infectious Diseases 2018 cited by 142

  20. Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective

    Authors: , , - Clinical Infectious Diseases 2022 cited by 77

  21. Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species

    Authors: , , - Clinical Microbiology Reviews 2011 cited by 434

  22. Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study

    Authors: , , , , , , , , , , , , , , - Infection Control and Hospital Epidemiology 2021 cited by 97

  23. The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study

    Authors: , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2019 cited by 68

  24. Zygomycosis in a Tertiary‐Care Cancer Center in the Era of Aspergillus‐ Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases

    Authors: , , , , , , , , , , - The Journal of Infectious Diseases 2005 cited by 677